We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Magellan's Unit to Improve Behavioral Health of Children
Read MoreHide Full Article
Magellan Health, Inc.’s healthcare business unit, Magellan Healthcare, recently partnered with Neuromotion, Inc. through which specific Magellan members can avail — Mightier — an in-home digital platform for children. Notably, this platform will be available through a pilot program.
Mightier, which has been developed by Neuromotion, is backed by a decade long of clinical research at Boston Children’s Hospital and Harvard Medical School. By integrating video games with clinically validated emotion calming skills, the Mightier program, intends to develop emotional skills in children, which in turn, is likely to boost their confidence. Notably, this can be achieved by staying within the comfort of one’s home.
The program even has the facility of a personalized dashboard through which a child’s progress can be observed. There will also be a licensed, master’s level clinician, who will train the child on a one-to-one basis.
Notably, Mightier has an impressive history of reaching out to more than 25,000 families globally in the past three years. Further, new families are being added constantly. Its worth mentioning that more than 75% of families reported improvements brought about by the clinical expertise of the Mightier program.
It has to be noted that behavioral health disorders are alarmingly increasing among children, which needs to be addressed at the earliest. Being a cost-effective one, the Mightier program enables children in efficiently managing their stress levels in a simplified way and provides relief to their families.
The fact that Magellan has brought this platform for its members bodes well, particularly at a time when individuals are restricted to their homes due to stringent social-distancing measures on account of the COVID-19 crisis. The pandemic, which has been affecting most people, can have an adverse impact on children staying at home. This impact can be addressed by the Mightier program to some extent.
Shares of this Zacks Rank #3 (Hold) healthcare provider have gained 14.5% in a year compared with the industry’s growth of 11.7%.
Moreover, Magellan has a strong network of providers specializing in autism, which enables it to offer appropriate services to children with autism. Per Centers for Disease Control and Prevention’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network, around 1 in 54 children have been diagnosed with autism spectrum disorder (ASD). Inconsistent provider quality, high costs and certain treatment standards have added to the woes as these often created hindrances in providing autism services.
Notably, the innovative technologies of the Mightier program even extend to children with autism. This when combined with the market-leading clinical expertise of Magellan is likely to bring about improved behavioral health outcomes for children with autism and behavioral health disorders.
Acadia Healthcare, GenMark and Cerner surpassed earnings estimates in each of the trailing four quarters by 4.77%, 13.49% and 3%, on average, respectively.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Magellan's Unit to Improve Behavioral Health of Children
Magellan Health, Inc.’s healthcare business unit, Magellan Healthcare, recently partnered with Neuromotion, Inc. through which specific Magellan members can avail — Mightier — an in-home digital platform for children. Notably, this platform will be available through a pilot program.
Mightier, which has been developed by Neuromotion, is backed by a decade long of clinical research at Boston Children’s Hospital and Harvard Medical School. By integrating video games with clinically validated emotion calming skills, the Mightier program, intends to develop emotional skills in children, which in turn, is likely to boost their confidence. Notably, this can be achieved by staying within the comfort of one’s home.
The program even has the facility of a personalized dashboard through which a child’s progress can be observed. There will also be a licensed, master’s level clinician, who will train the child on a one-to-one basis.
Notably, Mightier has an impressive history of reaching out to more than 25,000 families globally in the past three years. Further, new families are being added constantly. Its worth mentioning that more than 75% of families reported improvements brought about by the clinical expertise of the Mightier program.
It has to be noted that behavioral health disorders are alarmingly increasing among children, which needs to be addressed at the earliest. Being a cost-effective one, the Mightier program enables children in efficiently managing their stress levels in a simplified way and provides relief to their families.
The fact that Magellan has brought this platform for its members bodes well, particularly at a time when individuals are restricted to their homes due to stringent social-distancing measures on account of the COVID-19 crisis. The pandemic, which has been affecting most people, can have an adverse impact on children staying at home. This impact can be addressed by the Mightier program to some extent.
Shares of this Zacks Rank #3 (Hold) healthcare provider have gained 14.5% in a year compared with the industry’s growth of 11.7%.
Moreover, Magellan has a strong network of providers specializing in autism, which enables it to offer appropriate services to children with autism. Per Centers for Disease Control and Prevention’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) Network, around 1 in 54 children have been diagnosed with autism spectrum disorder (ASD). Inconsistent provider quality, high costs and certain treatment standards have added to the woes as these often created hindrances in providing autism services.
Notably, the innovative technologies of the Mightier program even extend to children with autism. This when combined with the market-leading clinical expertise of Magellan is likely to bring about improved behavioral health outcomes for children with autism and behavioral health disorders.
Stocks to Consider
Some better-ranked stocks in the medical space are Acadia Healthcare Company, Inc. (ACHC - Free Report) , GenMark Diagnostics, Inc. and Cerner Corporation , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Acadia Healthcare, GenMark and Cerner surpassed earnings estimates in each of the trailing four quarters by 4.77%, 13.49% and 3%, on average, respectively.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>